MX2020002142A - Un procedimiento para la preparacion de compuesto de triaminopirimidina e intermediarios del mismo. - Google Patents
Un procedimiento para la preparacion de compuesto de triaminopirimidina e intermediarios del mismo.Info
- Publication number
- MX2020002142A MX2020002142A MX2020002142A MX2020002142A MX2020002142A MX 2020002142 A MX2020002142 A MX 2020002142A MX 2020002142 A MX2020002142 A MX 2020002142A MX 2020002142 A MX2020002142 A MX 2020002142A MX 2020002142 A MX2020002142 A MX 2020002142A
- Authority
- MX
- Mexico
- Prior art keywords
- intermediates
- preparation
- triaminopyrimidine compound
- relates
- triaminopyrimidine
- Prior art date
Links
- -1 triaminopyrimidine compound Chemical class 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 title abstract 2
- 229940125904 compound 1 Drugs 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- CSNFMBGHUOSBFU-UHFFFAOYSA-N pyrimidine-2,4,5-triamine Chemical compound NC1=NC=C(N)C(N)=N1 CSNFMBGHUOSBFU-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201721031453 | 2017-09-05 | ||
| IN201721034342 | 2017-09-27 | ||
| PCT/IB2018/056732 WO2019049021A1 (en) | 2017-09-05 | 2018-09-04 | PROCESS FOR THE PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND ITS INTERMEDIATES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020002142A true MX2020002142A (es) | 2020-07-20 |
Family
ID=63684213
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020002142A MX2020002142A (es) | 2017-09-05 | 2018-09-04 | Un procedimiento para la preparacion de compuesto de triaminopirimidina e intermediarios del mismo. |
| MX2024002113A MX2024002113A (es) | 2017-09-05 | 2020-02-25 | Un procedimiento para la preparacion de compuesto de triaminopirimidina e intermediarios del mismo. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024002113A MX2024002113A (es) | 2017-09-05 | 2020-02-25 | Un procedimiento para la preparacion de compuesto de triaminopirimidina e intermediarios del mismo. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12378223B2 (enExample) |
| EP (1) | EP3679030B1 (enExample) |
| JP (1) | JP2020532513A (enExample) |
| CN (1) | CN111051299A (enExample) |
| CA (1) | CA3071226A1 (enExample) |
| ES (1) | ES2979379T3 (enExample) |
| MX (2) | MX2020002142A (enExample) |
| PH (1) | PH12020500385A1 (enExample) |
| WO (1) | WO2019049021A1 (enExample) |
| ZA (1) | ZA202000903B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025115034A1 (en) * | 2023-11-30 | 2025-06-05 | Zydus Lifesciences Limited | A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58124B1 (sr) * | 2014-04-28 | 2019-02-28 | Medicines For Malaria Venture Mmv | Triaminopirimidin jedinjenja korisna za prevenciju ili tretman malarije |
-
2018
- 2018-09-04 EP EP18778565.4A patent/EP3679030B1/en active Active
- 2018-09-04 US US16/640,491 patent/US12378223B2/en active Active
- 2018-09-04 JP JP2020511759A patent/JP2020532513A/ja not_active Withdrawn
- 2018-09-04 CN CN201880055980.1A patent/CN111051299A/zh active Pending
- 2018-09-04 MX MX2020002142A patent/MX2020002142A/es unknown
- 2018-09-04 ES ES18778565T patent/ES2979379T3/es active Active
- 2018-09-04 CA CA3071226A patent/CA3071226A1/en active Pending
- 2018-09-04 WO PCT/IB2018/056732 patent/WO2019049021A1/en not_active Ceased
-
2020
- 2020-02-12 ZA ZA2020/00903A patent/ZA202000903B/en unknown
- 2020-02-25 MX MX2024002113A patent/MX2024002113A/es unknown
- 2020-02-27 PH PH12020500385A patent/PH12020500385A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202000903B (en) | 2024-07-31 |
| EP3679030B1 (en) | 2024-03-27 |
| US12378223B2 (en) | 2025-08-05 |
| EP3679030A1 (en) | 2020-07-15 |
| JP2020532513A (ja) | 2020-11-12 |
| MX2024002113A (es) | 2024-03-06 |
| PH12020500385A1 (en) | 2020-12-07 |
| CN111051299A (zh) | 2020-04-21 |
| US20200207738A1 (en) | 2020-07-02 |
| CA3071226A1 (en) | 2019-03-14 |
| BR112020003557A2 (pt) | 2020-09-01 |
| WO2019049021A1 (en) | 2019-03-14 |
| ES2979379T3 (es) | 2024-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020500529A1 (en) | Bicyclic heterocyclyl derivatives as irak4 inhibitors | |
| ZA202206923B (en) | New methylquinazolinone derivatives | |
| SA520411524B1 (ar) | مركبات تنشيط القسيم العضلي ثنائي الأميد واستخداماتها | |
| SA519401336B1 (ar) | تركيبة صيدلية | |
| PH12020550792A1 (en) | Compounds useful for inhibiting cdk7 | |
| SG10201811384TA (en) | Mnk inhibitors and methods related thereto | |
| GEAP201814248A (en) | 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease | |
| PH12021551873A1 (en) | Hydroxypyridoxazepines as nrf2 activators | |
| SG11201906688VA (en) | Novel ester compounds, method for the production thereof and use thereof | |
| NZ762437A (en) | Novel heterocyclic compounds as cdk8/19 inhibitors | |
| TN2016000489A1 (en) | Carboxamide derivatives. | |
| PH12017500029A1 (en) | 4,5-dihydroisoxazole derivatives as nampt inhibitors | |
| WO2019194773A3 (en) | The combination comprising linagliptin and metformin | |
| TN2016000491A1 (en) | Carboxamide derivatives. | |
| TN2017000342A1 (en) | Novel cyclopropabenzofuranyl pyridopyrazinediones | |
| MY193041A (en) | Novel fused imidazobenzothiazole compounds | |
| PH12020500385A1 (en) | A process for preparation of triaminopyrimidine compound and intermediates thereof | |
| PH12019502852A1 (en) | Novel compounds activating the nrf2 pathway | |
| WO2020032885A3 (en) | Capsule-in-capsule compositions of dabigatran etexilate | |
| WO2019004980A3 (en) | SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN DEXILATE | |
| TR201714882A2 (tr) | Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari | |
| NZ759901A (en) | Solid oral pharmaceutical compositions of dabigatran etexilate | |
| MY208423A (en) | Composition of aminopyran derivative | |
| IN2014KO00191A (enExample) | ||
| GR1008804B (el) | Συνθεσεις για ιατρικη χρηση οι οποιες περιλαμβανουν υαλουρονικο οξυ ή αλατα αυτου, αμινοξεα, βιταμινες, ανοργανα αλατα και αλλα συστατικα |